🚀 VC round data is live in beta, check it out!
CME Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for CME Group and similar public comparables like Intercontinental Exchange, HKEX, London Stock Exchange Group, Deutsche Börse and more.
CME Group Overview
About CME Group
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
Founded
2001
HQ
Employees
3.8K
Website
Sectors
Financials (LTM)
EV
$110B
CME Group Financials
CME Group reported last 12-month revenue of $7B and EBITDA of $5B.
In the same LTM period, CME Group generated $5B in EBITDA and $4B in net income.
Revenue (LTM)
CME Group P&L
In the most recent fiscal year, CME Group reported revenue of $7B and EBITDA of $6B.
CME Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $7B | XXX | $7B | XXX | XXX | XXX |
| Gross Profit | — | XXX | $6B | XXX | XXX | XXX |
| Gross Margin | — | XXX | 86% | XXX | XXX | XXX |
| EBITDA | $5B | XXX | $6B | XXX | XXX | XXX |
| EBITDA Margin | 72% | XXX | 89% | XXX | XXX | XXX |
| EBIT Margin | 70% | XXX | 69% | XXX | XXX | XXX |
| Net Profit | $4B | XXX | $4B | XXX | XXX | XXX |
| Net Margin | 62% | XXX | 62% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
CME Group Stock Performance
CME Group has current market cap of $111B, and enterprise value of $110B.
Market Cap Evolution
CME Group's stock price is $305.11.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $110B | $111B | -6.5% | XXX | XXX | XXX | $11.22 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCME Group Valuation Multiples
CME Group trades at 16.4x EV/Revenue multiple, and 23.0x EV/EBITDA.
EV / Revenue (LTM)
CME Group Financial Valuation Multiples
As of April 7, 2026, CME Group has market cap of $111B and EV of $110B.
Equity research analysts estimate CME Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
CME Group has a P/E ratio of 26.9x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $111B | XXX | $111B | XXX | XXX | XXX |
| EV (current) | $110B | XXX | $110B | XXX | XXX | XXX |
| EV/Revenue | 16.4x | XXX | 16.8x | XXX | XXX | XXX |
| EV/EBITDA | 23.0x | XXX | 18.8x | XXX | XXX | XXX |
| EV/EBIT | 23.6x | XXX | 24.2x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 19.5x | XXX | XXX | XXX |
| P/E | 26.9x | XXX | 27.2x | XXX | XXX | XXX |
| EV/FCF | 24.8x | XXX | 22.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified CME Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
CME Group Margins & Growth Rates
CME Group's revenue in the last 12 month grew by 7%.
CME Group's revenue per employee in the last FY averaged $1.7M, while opex per employee averaged $0.6M for the same period.
CME Group's rule of 40 is 82% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
CME Group's rule of X is 94% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
CME Group Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 7% | XXX | 8% | XXX | XXX | XXX |
| EBITDA Margin | 72% | XXX | 89% | XXX | XXX | XXX |
| EBITDA Growth | 10% | XXX | (11%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 82% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 94% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $1.7M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.6M | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 4% | XXX | 4% | XXX | XXX | XXX |
| Opex to Revenue | 34% | XXX | 35% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
CME Group Public Comps
See public comps and valuation multiples for other Stock Exchanges comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Intercontinental Exchange | XXX | XXX | XXX | XXX | XXX | XXX |
| HKEX | XXX | XXX | XXX | XXX | XXX | XXX |
| London Stock Exchange Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Deutsche Börse | XXX | XXX | XXX | XXX | XXX | XXX |
| Nasdaq | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
CME Group M&A Activity
CME Group acquired XXX companies to date.
Last acquisition by CME Group was on XXXXXXXX, XXXXX. CME Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by CME Group
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCME Group Investment Activity
CME Group invested in XXX companies to date.
CME Group made its latest investment on XXXXXXXX, XXXXX. CME Group invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by CME Group
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout CME Group
| When was CME Group founded? | CME Group was founded in 2001. |
| Where is CME Group headquartered? | CME Group is headquartered in United States. |
| How many employees does CME Group have? | As of today, CME Group has over 3K employees. |
| Who is the CEO of CME Group? | CME Group's CEO is Terrence A. Duffy. |
| Is CME Group publicly listed? | Yes, CME Group is a public company listed on Nasdaq. |
| What is the stock symbol of CME Group? | CME Group trades under CME ticker. |
| When did CME Group go public? | CME Group went public in 2002. |
| Who are competitors of CME Group? | CME Group main competitors are Intercontinental Exchange, HKEX, London Stock Exchange Group, Deutsche Börse. |
| What is the current market cap of CME Group? | CME Group's current market cap is $111B. |
| What is the current revenue of CME Group? | CME Group's last 12 months revenue is $7B. |
| What is the current revenue growth of CME Group? | CME Group revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of CME Group? | Current revenue multiple of CME Group is 16.4x. |
| Is CME Group profitable? | Yes, CME Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of CME Group? | CME Group's last 12 months EBITDA is $5B. |
| What is CME Group's EBITDA margin? | CME Group's last 12 months EBITDA margin is 72%. |
| What is the current EV/EBITDA multiple of CME Group? | Current EBITDA multiple of CME Group is 23.0x. |
| What is the current FCF of CME Group? | CME Group's last 12 months FCF is $4B. |
| What is CME Group's FCF margin? | CME Group's last 12 months FCF margin is 66%. |
| What is the current EV/FCF multiple of CME Group? | Current FCF multiple of CME Group is 24.8x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.